TESARO, Inc (TSRO) Covered Calls

TESARO, Inc covered calls TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

There are no covered calls available for TESARO, Inc.

Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

TESARO, Inc. is an oncology-focused biopharmaceutical company. It is dedicated to improving the lives of cancer patients. The company's product portfolio currently consists of three oncology-related product candidates: Rolapitant, Niraparib and TSR-011. TESARO was founded by Leon Moulder, Jr., Mary Lynne Hedley and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.